Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2caaba601fd6460c7b37706d920d42e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28232e7448d0d6434c353678b7098174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a445acc0459ca0bbf1a078a028ad83e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151b11ab8fdf8024c8f4418deb3e0f7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bbdfdaf4f3c551bbb9f44fae17c66e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12427d1f65d7e3b41b4e949b27e1f66e |
publicationDate |
2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022031801-A1 |
titleOfInvention |
METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST |
abstract |
The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766468-B2 |
priorityDate |
2008-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |